Skip to main content
. Author manuscript; available in PMC: 2016 Mar 17.
Published in final edited form as: Mult Scler. 2015 Apr 28;22(2):185–192. doi: 10.1177/1352458515581438

Figure 1.

Figure 1

Median EDSS changes in the IVMP-only group: Baseline EDSS of 2.5 rose to 4.5 on presentation and declined to 4 on discharge and remained at 4 at follow-up.

EDSS: Expanded Disability Status Scale; IVMP: intravenous methylprednisolone.